PORTFASTFLU - Potrable and Automated Test for Fast Detection and Surveillance of Influenza

PORTFASTFLU is a €3.8 million, European Union FP7 funded project which aims to develop and validate a rapid diagnostic system for influenza that will be used for surveillance and early detection of influenza, and as a point-of-care tool in developed and developing countries.

The system will be fully automated, and will combine microfluidic based RNA extraction and RT-PCR with real-time microarray in one small footprint machine. The device will allow on site detection of influenza virus in clinical or veterinary samples, including avian and current porcine flu, as well as H and N subtyping of the other various influenza known viruses.

Partners in the Portfastflu research project are Coordinator Genewave (Evry & Palaiseau, France) Nottingham Trent University (Nottingham, UK) Biosensia (Dublin, Ireland) CIRAD (Montpellier, France) VIB University of Ghent (Ghent, Belgium) Ikerlan (Mondragon, Spain) Gaiker (Zamudio, Spain) Basque Foundation for Health Innovation and Research (San Sebastian, Spain) Whatman (Maidstone, UK).

The technology would improve the diagnosis time for all forms of influenza, including H5N1 avian influenza and H1N1 porcine flu. In the event of an emerging pandemic Influenza, the ability to rapidly diagnose and type influenza virus in the field would have enormous impact on the spread of the outbreak, reducing human cases and mortality rates.

The technology could also prove to be a vital tool in the fight against high and low pathogenic avian influenza, making it possible to set up exclusion zones and cull infected birds much faster, before infection spreads. This preventative measure is seen by many countries as highly beneficial to the controversial use of avian influenza vaccines.

Halfway through the project (April 2009), capacity to identify the various strains (type A, H1N1, H2N3, H3N2, H5N1, H5N2, H7N1, H7N7, H9N2, H9N9 et type B) has been demonstrated. Clinical tests in hospitals and in the field will start in December 2009.

For further information, please visit:
http://www.portfastflu.com

Most Popular Now

MEDICA 2024 + COMPAMED 2024: Adapted Hal…

11 - 14 November 2024, Düsseldorf, Germany. The final preparations for MEDICA 2024 and COMPAMED 2024 in Düsseldorf have begun. A total of more than 5,500 exhibitors from approximately 70 countries...

AI does Not Necessarily Lead to more Eff…

The use of artificial intelligence (AI) in hospitals and patient care is steadily increasing. Especially in specialist areas with a high proportion of imaging, such as radiology, AI has long...

Commission Joins Forces with Venture Cap…

The Commission has launched a Trusted Investors Network bringing together a group of investors ready to co-invest in innovative deep-tech companies in Europe together with the EU. The Union's investment...

Why the NHS is Seeking to Make Media Ser…

Opinion Article by Dean Moody, Healthcare Services Director, Airwave Healthcare. Tim Kelsey and Martha Lane Fox called for WiFi to be made available free of charge throughout the NHS back in...

An AI-Powered Pipeline for Personalized …

Ludwig Cancer Research scientists have developed a full, start-to-finish computational pipeline that integrates multiple molecular and genetic analyses of tumors and the specific molecular targets of T cells and harnesses...

Philips and Medtronic Advocacy Partnersh…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Medtronic Neurovascular, a leading innovator in neurovascular therapies, today announced a strategic advocacy partnership. Delivering timely stroke...

Wearable Cameras Allow AI to Detect Medi…

A team of researchers says it has developed the first wearable camera system that, with the help of artificial intelligence (AI), detects potential errors in medication delivery. In a test whose...

AI could Transform How Hospitals Produce…

A pilot study led by researchers at University of California San Diego School of Medicine found that advanced artificial intelligence (AI) could potentially lead to easier, faster and more efficient...

New AI Tool Predicts Protein-Protein Int…

Scientists from Cleveland Clinic and Cornell University have designed a publicly-available software and web database to break down barriers to identifying key protein-protein interactions to treat with medication. The computational tool...

AI for Real-Rime, Patient-Focused Insigh…

A picture may be worth a thousand words, but still... they both have a lot of work to do to catch up to BiomedGPT. Covered recently in the prestigious journal Nature...

Start-Ups will Once Again Have a Starrin…

11 - 14 November 2024, Düsseldorf, Germany. The finalists in the 16th Healthcare Innovation World Cup and the 13th MEDICA START-UP COMPETITION have advanced from around 550 candidates based in 62...

G-Cloud 14 Makes it Easier for NHS to Bu…

NHS organisations will be able to save valuable time and resource in the procurement of technologies that can make a significant difference to patient experience, in the latest iteration of...